Sera Prognostics, Inc. - Class A Common Stock (SERA)
1.7500
-0.1400 (-7.41%)
NASDAQ· Last Trade: Jun 21st, 5:41 AM EDT
Detailed Quote
Previous Close
1.890
Open
1.880
Bid
1.780
Ask
1.940
Day's Range
1.750 - 1.940
52 Week Range
1.560 - 4.090
Volume
87,456
Market Cap
51.26M
PE Ratio (TTM)
-2.273
EPS (TTM)
-0.8
Dividend & Yield
N/A (N/A)
1 Month Average Volume
76,857
Chart
About Sera Prognostics, Inc. - Class A Common Stock (SERA)
Sera Prognostics Inc is a biotechnology company focused on advancing maternal and fetal health through innovative diagnostic solutions. The company primarily develops predictive tests that aim to assess the risk of pregnancy complications, enabling healthcare providers to offer personalized care and interventions for expectant mothers and their babies. By harnessing advanced biomarker analysis and machine learning technologies, Sera Prognostics seeks to improve pregnancy outcomes and reduce healthcare costs associated with managing high-risk pregnancies. Their commitment to research and collaboration with healthcare professionals highlights their dedication to enhancing the overall well-being of mothers and infants. Read More
Sera Prognostics (NASDAQ:SERA) reported mixed Q2 2025 results: EPS beat estimates with a $0.16 loss, but revenue missed at $20K. Shares rose 1.8% after hours.
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
